BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10519385)

  • 1. Functional activity of ectopically expressed estrogen receptor is not sufficient for estrogen-mediated cyclin D1 expression.
    Planas-Silva MD; Donaher JL; Weinberg RA
    Cancer Res; 1999 Oct; 59(19):4788-92. PubMed ID: 10519385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIB1 enhances estrogen-dependent induction of cyclin D1 expression.
    Planas-Silva MD; Shang Y; Donaher JL; Brown M; Weinberg RA
    Cancer Res; 2001 May; 61(10):3858-62. PubMed ID: 11358796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
    Li H; Weinstein IB
    Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.
    Nakuci E; Mahner S; Direnzo J; ElShamy WM
    Exp Cell Res; 2006 Oct; 312(16):3120-31. PubMed ID: 16860316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.
    Balasenthil S; Barnes CJ; Rayala SK; Kumar R
    FEBS Lett; 2004 Jun; 567(2-3):243-7. PubMed ID: 15178330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen-induced proliferation of normal endometrial glandular cells is initiated by transcriptional activation of cyclin D1 via binding of c-Jun to an AP-1 sequence.
    Shiozawa T; Miyamoto T; Kashima H; Nakayama K; Nikaido T; Konishi I
    Oncogene; 2004 Nov; 23(53):8603-10. PubMed ID: 15467760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells.
    Davis T; Kennedy C; Chiew YE; Clarke CL; deFazio A
    Clin Cancer Res; 2000 Nov; 6(11):4334-42. PubMed ID: 11106251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells.
    Kilker RL; Hartl MW; Rutherford TM; Planas-Silva MD
    J Steroid Biochem Mol Biol; 2004 Sep; 92(1-2):63-71. PubMed ID: 15544931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM; Klein RC; Oka M; Cowan KH
    Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines.
    Crowe DL; Brown TN; Kim R; Smith SM; Lee MK
    Mol Cell Biol Res Commun; 2000 Apr; 3(4):243-8. PubMed ID: 10891399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
    Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV
    Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1.
    Mawson A; Lai A; Carroll JS; Sergio CM; Mitchell CJ; Sarcevic B
    Mol Cell Endocrinol; 2005 Jan; 229(1-2):161-73. PubMed ID: 15607540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive overexpression of cyclin D1 does not prevent inhibition of hormone-responsive human breast cancer cell growth by antiestrogens.
    Pacilio C; Germano D; Addeo R; Altucci L; Petrizzi VB; Cancemi M; Cicatiello L; Salzano S; Lallemand F; Michalides RJ; Bresciani F; Weisz A
    Cancer Res; 1998 Mar; 58(5):871-6. PubMed ID: 9500441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter.
    Cicatiello L; Addeo R; Sasso A; Altucci L; Petrizzi VB; Borgo R; Cancemi M; Caporali S; Caristi S; Scafoglio C; Teti D; Bresciani F; Perillo B; Weisz A
    Mol Cell Biol; 2004 Aug; 24(16):7260-74. PubMed ID: 15282324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype.
    Smith LM; Wise SC; Hendricks DT; Sabichi AL; Bos T; Reddy P; Brown PH; Birrer MJ
    Oncogene; 1999 Oct; 18(44):6063-70. PubMed ID: 10557095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative activity of melatonin by transcriptional inhibition of cyclin D1 expression: a molecular basis for melatonin-induced oncostatic effects.
    Cini G; Neri B; Pacini A; Cesati V; Sassoli C; Quattrone S; D'Apolito M; Fazio A; Scapagnini G; Provenzani A; Quattrone A
    J Pineal Res; 2005 Aug; 39(1):12-20. PubMed ID: 15978052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y; Chen S
    Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer.
    Aaltonen K; Amini RM; Landberg G; Eerola H; Aittomäki K; Heikkilä P; Nevanlinna H; Blomqvist C
    Breast Cancer Res Treat; 2009 Jan; 113(1):75-82. PubMed ID: 18240019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
    Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M
    Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.